Murdoch Children’s Research Institute launches an international trial of a 21-valent pneumococcal vaccine to protect babies against pneumonia, meningitis, and sepsis.
The NHS is starting the world’s first vaccine programme to prevent gonorrhoea, using the 4CMenB meningitis vaccine in high‑risk groups from August 2025.
Stanford researchers have developed an AI-powered "virtual scientist" capable of designing drug and vaccine candidates, marking a leap forward in biomedical research.
The NHS will offer a long-acting antibody injection to protect thousands of premature and vulnerable babies from respiratory syncytial virus (RSV) starting this autumn.
The University of Oxford has become the first UK academic institution to receive support from the European Medicines Agency's (EMA) PRIority MEdicines (PRIME) scheme for its vaccine targeting the deadly Nipah virus.
BioNTech, the German biopharmaceutical company behind one of the world's first COVID-19 vaccines, has announced a landmark investment of up to £1 billion in the UK over the next decade.
An innovative fridge-free vaccine will enter its first-in-human clinical trial at the National Institute for Health and Care Research (NIHR) Southampton Clinical Research Facility.
The UK Health Security Agency (UKHSA) has released a new tool that will help research and development efforts of diagnostics, vaccines, and treatments for pathogens that pose the greatest risk to public health.
An ageing population, rising antimicrobial resistance, and the ongoing threat of infectious and chronic diseases are placing immense pressure on our societies. A shift to a preventative approach is necessary for the efficiency and sustainability of our healthcare systems. Central to this shift is the often-underutilized tool of life-course immunization.
Researchers have made a new discovery in the fight against malaria. The study, recently published in Science, identified a new class of antibodies targeting a previously unexplored malaria parasite region.
